United Therapeutics
UTHR
#993
Rank
S$30.57 B
Marketcap
S$720.26
Share price
-0.51%
Change (1 day)
79.72%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: S$30.57 Billion

As of May 2026 United Therapeutics has a market cap of S$30.57 Billion. This makes United Therapeutics the world's 993th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026S$30.57 B3.82%
2025S$29.44 B34.82%
2024S$21.84 B60.06%
2023S$13.64 B-19.68%
2022S$16.99 B29.15%
2021S$13.15 B47.42%
2020S$8.92 B71.25%
2019S$5.21 B-19.64%
2018S$6.48 B-24.16%
2017S$8.55 B-2.89%
2016S$8.80 B-13.14%
2015S$10.13 B25.77%
2014S$8.06 B11.65%
2013S$7.21 B120.28%
2012S$3.27 B-8.19%
2011S$3.56 B-23.84%
2010S$4.68 B16.95%
2009S$4.00 B92.88%
2008S$2.07 B-33.53%
2007S$3.12 B74.61%
2006S$1.79 B-33.28%
2005S$2.68 B62.44%
2004S$1.65 B98.82%
2003S$0.83 B37.05%
2002S$0.60 B55.55%
2001S$0.38 B-25.39%
2000S$0.52 B-57.38%
1999S$1.22 B

End of Day market cap according to different sources

On May 19th, 2026 the market cap of United Therapeutics was reported to be:

S$30.72 Billion
by Nasdaq info icon info icon
S$30.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$187.73 B 514.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.160 T 3,695.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$12.38 B-59.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$207.24 B 577.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$59.59 B 94.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$130.14 B 325.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
S$13.65 B-55.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.04 B 66.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel